UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Editorial Expression of Concern: Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures

Clinical rheumatology, 2021-08, Vol.40 (8), p.3387-3387

2021

Volltextzugriff (PDF)

Retraction Note: Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis

Clinical rheumatology, 2021-08, Vol.40 (8), p.3383-3383

2021

Volltextzugriff (PDF)

Retraction Note: Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

Clinical rheumatology, 2021-08, Vol.40 (8), p.3385-3385

2021

Volltextzugriff (PDF)

Retraction Note to: Effect of alendronate on bone mineral density and bone turnovermarkers in post-gastrectomy osteoporotic patients

Journal of bone and mineral metabolism, 2021-05, Vol.39 (3), p.521-521

2021

Volltextzugriff (PDF)

Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures

Clinical rheumatology, 2016-01, Vol.35 (1), p.205-212

2016

Volltextzugriff (PDF)

Establishment of an appropriate fall prevention program: A community‐based study

Geriatrics & gerontology international, 2017-07, Vol.17 (7), p.1081-1089

2017

Volltextzugriff (PDF)

Effect of alendronate on bone mineral density and bone turnover markers in post-gastrectomy osteoporotic patients

Journal of bone and mineral metabolism, 2010-03, Vol.28 (2), p.202-208

2010

Volltextzugriff (PDF)

Comparative effect of alendronate and teriparatide on bone mineral density and bone turnover among Japanese postmenopausal women with history of fragility fractures: A clinical practice-based observational study

Osteoporosis and Sarcopenia, 2015, 1(1), 1, pp.63-69

2015

Volltextzugriff (PDF)

Retraction: Paper “Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures” by Iwamoto J, et al. [Yonsei Med J 2009 Aug;50(4):474-481]

Yonsei medical journal, 2023-03, p.228-228

2023

Volltextzugriff (PDF)

Retraction: Paper "Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures" by Iwamoto J, et al. [Yonsei Med J 2009 Aug;50(4):474-481]

Yonsei Medical Journal, 2023, 64(3), , pp.228-228

2023

Volltextzugriff (PDF)

Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

Clinical rheumatology, 2007-02, Vol.26 (2), p.161-167

2007

Volltextzugriff (PDF)

Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis

Therapeutics and clinical risk management, 2010-01, Vol.6, p.201-206

2010

Volltextzugriff (PDF)

Comparison of the effects of alendronate and alfacalcidol on hip bone mineral density and bone turnover in Japanese men having osteoporosis or osteopenia with clinical risk factors for fractures

Yonsei Medical Journal, 2009, 50(4), , pp.474-481

2009

Volltextzugriff (PDF)

A Radiographic Study on the Associations of Age and Prevalence of Vertebral Fractures with Abdominal Aortic Calcification in Japanese Postmenopausal Women and Men

Journal of Osteoporosis, 2010-01, Vol.2010, p.748380-6

2010

Volltextzugriff (PDF)

Retraction Note: Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction: A Retrospective Study

Drugs & aging, 2019-10, Vol.36 (10), p.979-979

2019

Volltextzugriff (PDF)

Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis

Clinical rheumatology, 2004-10, Vol.23 (5), p.383-389

2004

Volltextzugriff (PDF)

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures

Therapeutics and clinical risk management, 2010-12, Vol.6, p.593-600

2010

Volltextzugriff (PDF)

Retraction Note to: Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate

Aging clinical and experimental research, 2019-12, Vol.31 (12), p.1855-1855

2019

Volltextzugriff (PDF)

Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis

Journal of bone and mineral metabolism, 2005-05, Vol.23 (3), p.238-242

2005

Volltextzugriff (PDF)

RETRACTED ARTICLE: Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

Clinical rheumatology, 2007-02, Vol.26 (2), p.161-167

2007

Volltextzugriff (PDF)

Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]

Therapeutics and clinical risk management, 2022-08, Vol.18, p.785-786

2022

Volltextzugriff (PDF)

Efficacy of training program for ambulatory competence in elderly women

The Keio Journal of Medicine, 2004, Vol.53(2), pp.85-89

2004

Volltextzugriff (PDF)

Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2003-07, Vol.8 (4), p.532-537

2003

Volltextzugriff (PDF)

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis

Therapeutics and clinical risk management, 2009-07, Vol.5 (3), p.499-505

2009

Volltextzugriff (PDF)

Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetes

Diabetes research and clinical practice, 2011-08, Vol.93 (2), p.166-173

2011

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(59)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Osteoporosis
(25)
Bone Mineral Density
(21)
Aged
(19)
Humans
(19)
Alendronate
(18)
Middle Aged
(17)
Female
(16)
Fractures
(14)
Aged, 80 And Over
(13)
Bone Density - Drug Effects
(12)
Osteoporosis, Postmenopausal - Drug Therapy
(11)
Bone Density
(10)
Bone Turnover
(10)
Health Care Sciences & Services
(9)
Alendronate - Therapeutic Use
(8)
Medicine & Public Health
(8)
Biological And Medical Sciences
(7)
Lumbar Vertebrae - Drug Effects
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Editorial Expression of Concern: Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures

Retraction Note: Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis

Retraction Note: Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

Retraction Note to: Effect of alendronate on bone mineral density and bone turnovermarkers in post-gastrectomy osteoporotic patients

Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures

Establishment of an appropriate fall prevention program: A community‐based study

Effect of alendronate on bone mineral density and bone turnover markers in post-gastrectomy osteoporotic patients

Comparative effect of alendronate and teriparatide on bone mineral density and bone turnover among Japanese postmenopausal women with history of fragility fractures: A clinical practice-based observational study

Retraction: Paper “Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures” by Iwamoto J, et al. [Yonsei Med J 2009 Aug;50(4):474-481]

Retraction: Paper "Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures" by Iwamoto J, et al. [Yonsei Med J 2009 Aug;50(4):474-481]

Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

Seven years' experience with alendronate in postmenopausal Japanese women with osteoporosis

Comparison of the effects of alendronate and alfacalcidol on hip bone mineral density and bone turnover in Japanese men having osteoporosis or osteopenia with clinical risk factors for fractures

A Radiographic Study on the Associations of Age and Prevalence of Vertebral Fractures with Abdominal Aortic Calcification in Japanese Postmenopausal Women and Men

Retraction Note: Three-year Experience with Alendronate Treatment in Postmenopausal Osteoporotic Japanese Women with or without Renal Dysfunction: A Retrospective Study

Effects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosis

Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures

Retraction Note to: Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate

Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis

RETRACTED ARTICLE: Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

Experience with Alendronate Treatment for Four Years among Japanese Men with Osteoporosis or Osteopenia and Clinical Risk Factors for Fractures [Retraction]

Efficacy of training program for ambulatory competence in elderly women

Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis

Three-year experience with alendronate treatment in postmenopausal osteoporotic Japanese women with or without type 2 diabetes

Suchergebnisse filtern